Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer

Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer

Breast cancer is the most common cancer in women worldwide. The heterogeneity of breast cancer and drug resistance to therapies make the diagnosis and treatment difficult. Molecular imaging methods with positron emission tomography (PET) and single-photon emission tomography (SPECT) provide useful t...

Full description

Bibliographic Details
Main Authors: Hanyi Fang, Alessandra Cavaliere, Ziqi Li, Yiyun Huang, Bernadette Marquez-Nostra
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
theranostics (combined therapeutic and diagnostic technology)
breast cancer subtypes
molecular imaging
targeted therapy
preclinical (in-vivo) studies
positron emission tomography
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.627693/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.627693/full

Similar Items